InsiderTrades

Form 4 for GILD Gilead Sciences

Accepted 2024-05-09 00:00:00 ET · period of report 2024-05-08 · accession 0001127602-24-014812 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-05-09 2024-05-08 GILD MANWANI HARISH Dir F - Tax $64.92 -451 12.9K -3% -$29.3K
D 2024-05-09 2024-05-08 GILD MANWANI HARISH Dir A - Grant $0.00 +2,310 13.3K +21% $0
D 2024-05-09 2024-05-08 GILD MANWANI HARISH Dir A - Grant $0.00 +12.6K 12.6K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-05-08 F D 451 $64.92 12,873 D — —
2 Common Common Stock 2024-05-08 A A 2,310 $0.00 13,324 D — — (F1) Represents 2,310 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 8, 2024.
3 Derivative Non-qualified Stock Option (Right to Buy) 2024-05-08 A A 12,648 $0.00 12,648 D $64.92 · — to 2034-05-08 12,648 Common Stock (F2) 100% of the shares subject to the stock option vested immediately upon the grant date of May 8, 2024.